TCM Biotech International Corp. (TPEX: 4169)

TCM Biotech International Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	373.32	504.13	89.85	58.26	34.27	29.26
Short-Term Investments	200	-	0.09	-	-	-
Cash & Short-Term Investments	573.32	504.13	89.94	58.26	34.27	29.26
Cash Growth	722.87%	460.55%	54.38%	70.01%	17.11%	-65.83%
Accounts Receivable	135.76	259.08	225.83	190.68	167.95	165.89
Other Receivables	7.41	3.61	3.94	0.03	0.09	10
Receivables	143.17	262.69	229.77	190.71	168.05	175.89
Inventory	200.4	208.36	193.25	203.33	207.39	198.38
Prepaid Expenses	5.95	4.46	0.65	17.08	18.46	29.83
Other Current Assets	1.14	1.51	0.13	0.74	0.46	0.27
Total Current Assets	923.97	981.15	513.74	470.11	428.62	433.62
Property, Plant & Equipment	294.74	293.71	301.74	285.36	291.91	299.14
Other Intangible Assets	6.71	8.01	10.24	13.21	15.2	6.97
Long-Term Deferred Tax Assets	1.56	0.98	1.63	4.2	4.88	9.69
Long-Term Deferred Charges	15.66	15.66	15.66	16.26	14.59	4.33
Other Long-Term Assets	27.23	23.41	19.87	30.92	17.07	11.22
Total Assets	1,270	1,323	862.87	820.06	772.26	764.96
Accounts Payable	29.82	64.53	88.81	55.54	42.53	48.82
Accrued Expenses	22.7	50.18	52.01	36.84	35.41	29.01
Short-Term Debt	44	44	44	44	-	14.63
Current Portion of Long-Term Debt	9.05	5.19	10.44	9.21	9.6	9.54
Current Portion of Leases	3.59	1.68	2.95	1.84	2.16	1.15
Current Income Taxes Payable	2.34	2.59	2.35	-	3.51	3.06
Current Unearned Revenue	2.04	2.25	2.76	5.12	3.8	3.29
Other Current Liabilities	39.63	27.96	21.54	23.38	19.19	15.25
Total Current Liabilities	153.17	198.38	224.84	175.93	116.21	124.74
Long-Term Debt	54.19	59.69	93.58	104.51	113.89	123.57
Long-Term Leases	9.81	4.81	6.49	1.45	3.29	2.73
Long-Term Unearned Revenue	3.23	3.23	-	18.2	18.2	-
Long-Term Deferred Tax Liabilities	-	-	0.01	-	-	0.01
Other Long-Term Liabilities	1.38	0.27	0.27	0.16	0.16	-
Total Liabilities	221.78	267.88	326.2	301.84	255.02	254.24
Common Stock	590.49	590.49	475.92	475.92	475.92	475.92
Additional Paid-In Capital	415.77	415.77	13.82	13.82	12.09	12.09
Retained Earnings	41.88	48.85	47.04	28.47	42.34	35.84
Treasury Stock	-	-	-	-	-13.09	-13.09
Comprensive Income & Other	-0.05	-0.07	-0.11	0.01	-0.02	-0.05
Shareholders' Equity	1,048	1,055	536.67	518.22	517.24	510.71
Total Liabilities & Equity	1,270	1,323	862.87	820.06	772.26	764.96
Total Debt	120.64	115.38	157.46	161	128.94	151.6
Net Cash (Debt)	452.68	388.76	-67.52	-102.75	-94.67	-122.35
Net Cash Per Share	7.80	7.33	-1.38	-2.11	-1.95	-2.52
Filing Date Shares Outstanding	59.05	59.05	49.05	49.05	48.43	48.43
Total Common Shares Outstanding	59.05	59.05	49.05	49.05	48.43	48.43
Working Capital	770.79	782.78	288.9	294.18	312.41	308.88
Book Value Per Share	17.75	17.87	10.94	10.57	10.68	10.55
Tangible Book Value	1,041	1,047	526.43	505.01	502.04	503.75
Tangible Book Value Per Share	17.64	17.73	10.73	10.30	10.37	10.40
Land	83.08	83.08	83.08	83.08	83.08	83.08
Buildings	197.04	196.97	196.6	194.3	192.59	192.04
Machinery	103.61	101.48	93.09	77.69	71.78	71.44
Leasehold Improvements	10.44	10.33	9.76	3.41	2.72	7.44

Source: S&P Capital IQ. Standard template. Financial Sources.